We’re Evolving—Immortality.global 2.0 is Incubating
The platform is in maintenance while we finalize a release that blends AI and longevity science like never before.

May 22 in Longevity and AI

Gathered globally: 10, selected: 10.

The News Aggregator is an artificial intelligence system that gathers and filters global news on longevity and artificial intelligence, and provides tailored multilingual content of varying sophistication to help users understand what's happening in the world of longevity and AI.


Juvenescence has closed its Series B-1 financing round, securing $76 million led by Abu Dhabi’s M42. The collaboration establishes an AI-enabled drug development hub leveraging clinical data, genomics, and AI-driven discovery. This partnership accelerates Juvenescence’s pipeline of therapeutics against age-related diseases, spanning cognition, cardio-metabolism, immunity, and cellular repair to extend healthy lifespan.

Key points

  • Juvenescence raises $76 million in Series B-1 funding led by Abu Dhabi’s M42 to support its AI-driven longevity pipeline.
  • Partnership establishes an AI-enabled drug development hub integrating M42’s genomics and clinical-data infrastructure with Juvenescence’s discovery platform.
  • Therapeutic programs target cognition, cardiometabolic function, immune modulation, and cellular repair to address age-related disease hallmarks.

Why it matters: This strategic funding and partnership establish a scalable AI-driven platform to accelerate discovery of longevity therapeutics, potentially transforming age-related disease treatment.

Q&A

  • What is a Series B-1 financing round?
  • How does an AI-enabled drug development hub operate?
  • What are the hallmarks of aging targeted?
  • Why choose Abu Dhabi for this partnership?
Copy link
Facebook X LinkedIn WhatsApp
Share post via...
Juvenescence and M42 to build drug development hub in Abu Dhabi with focus on extending healthy lifespan.

University of Birmingham’s Genomics of Ageing and Rejuvenation Lab reports that lifespan-extending compounds induce significant weight loss that correlates with extended median and maximum lifespans in male mice, while female mice show weight loss without lifespan gains. Using the updated DrugAge database (Build 5) and standardized murine data, the team identifies sex-specific responses and underscores the importance of monitoring weight change in longevity research.

Key points

  • Standardized murine data from DrugAge Build 5 include ppm dosage, weight-change metrics, and lifespan outcomes.
  • A robust negative correlation (slope: –0.76; R²: 0.52) links weight loss to median lifespan extension in male mice under ITP protocols.
  • Female mice exhibit weight loss without corresponding lifespan benefits, highlighting sex-specific responses to geroprotective compounds.

Why it matters: This work shifts paradigms in aging research by revealing sex-specific, weight-linked mechanisms of drug-induced lifespan extension, guiding precision geroprotection strategies.

Q&A

  • What is the DrugAge database?
  • Why is weight change important in lifespan studies?
  • How do sex differences impact drug-induced longevity?
  • What are caloric restriction mimetics?
Copy link
Facebook X LinkedIn WhatsApp
Share post via...
Sex-specific insights into drug-induced lifespan extension and weight loss in mice

A multidisciplinary team from the University of Wollongong uses semistructured interviews with 72 stakeholders—clinicians, regulators, developers, and consumer representatives—to assess perceptions of algorithmic bias in healthcare AI. They identify divergent positions on bias existence, responsibility distribution, and handling sociocultural data, and advocate for combined sociolegal and technical interventions, including diverse datasets, open disclosure, and regulatory frameworks, supported by interdisciplinary collaboration to promote equitable AI deployment in clinical settings.

Key points

  • Conducted semistructured interviews with 72 multidisciplinary experts to map perspectives on algorithmic bias in healthcare AI.
  • Identified three opposing views on bias existence—critical, apologist, denialist—and conflicting stances on mitigation responsibility and sociocultural data inclusion.
  • Proposed integrated sociolegal measures (patient engagement, equity sampling, regulatory oversight) and data science strategies (governance, synthetic data, bias assessments) for fair AI deployment.

Why it matters: Addressing algorithmic bias in healthcare AI is essential to prevent perpetuating systemic inequities and ensure equitable patient outcomes across diverse populations.

Q&A

  • What is algorithmic bias?
  • How do bias assessment tools work?
  • Why is sociocultural data inclusion debated?
  • Who is responsible for mitigating AI bias?
Copy link
Facebook X LinkedIn WhatsApp
Share post via...
Practical, epistemic and normative implications of algorithmic bias in healthcare artificial intelligence: a qualitative study of multidisciplinary expert perspectives

A team at Alibaba develops the Orangutan framework, modeling multi-compartment neurons, diverse synaptic mechanisms, and cortical columns to implement sensorimotor loops and predictive coding, demonstrating dynamic saccadic vision control on MNIST and paving the way for biologically grounded AI.

Key points

  • Multi-compartment neuron modeling simulates dendritic logic (MAX/MIN), soma summation, axonal delays, and synaptic modulation per tick.
  • Implements diverse synaptic types—axo-dendritic, axo-somatic, axo-axonic, autaptic—with facilitation, shunting inhibition, STP, LTP parameters for dynamic plasticity.
  • Validates framework via a 3.7M-neuron, 56M-compartment, 13-region model performing MNIST saccadic vision, demonstrating dynamic perception-motion cycles.

Why it matters: This biologically grounded, multiscale AI framework offers a new paradigm for scalable, interpretable AGI with dynamic sensorimotor integration.

Q&A

  • What is a multi-compartment neuron model?
  • How does the framework simulate synaptic plasticity?
  • What is the sensorimotor saccadic model?
  • Why include cortical columns in AI simulations?
Copy link
Facebook X LinkedIn WhatsApp
Share post via...
A multiscale brain emulation-based artificial intelligence framework for dynamic environments

A team led by Peng Zhao at Army Medical University integrates MAP, buccal CO₂ (PBUCO₂), transcutaneous O₂ (PTCO₂), and pulse pressure variation (PPV) into a four-feature KNN classifier. Optimized via leave-one-out cross-validation (K=3) and benchmarked against an SVM, the model achieves AUC=1.00 at a 70:30 split, demonstrating robust shock stratification.

Key points

  • KNN classifier integrates four noninvasive metrics—MAP, PBUCO₂, PTCO₂, and PPV—in a four-dimensional feature space, selecting K=3 via leave-one-out cross-validation.
  • The model achieves 94.82% accuracy and perfect AUC=1.00 at a 70:30 train-test split, with average F1-score of 95.09% across four blood-loss classes.
  • An SVM baseline (RBF kernel, C=1) yields lower accuracy (~82.76%) and AUC (~0.97), confirming KNN’s advantage for small-sample biomedical classification.

Why it matters: Demonstrating near-perfect shock severity classification with simple noninvasive metrics, this KNN approach could transform rapid prehospital trauma assessment and inform predictive health monitoring.

Q&A

  • What is pulse pressure variation?
  • How does the KNN algorithm work?
  • Why compare KNN with SVM?
  • What are PBUCO₂ and PTCO₂ measurements?
  • How is leave-one-out cross-validation applied?
Copy link
Facebook X LinkedIn WhatsApp
Share post via...
A KNN-based model for non-invasive prediction of hemorrhagic shock severity in prehospital settings: integrating MAP, PBUCO2, PTCO2, and PPV

Researchers Chakrabarti and Chattopadhyay review evidence that imbalances in the gut microbiome modulate genomic stability and telomere attrition by influencing inflammatory and oxidative pathways. Pathogenic strains produce genotoxins that exacerbate DNA damage, whereas beneficial SCFA-producing bacteria preserve telomere length. They highlight dietary, probiotic, and FMT interventions as strategies to restore microbial balance and promote healthy longevity.

Key points

  • Pathogenic bacteria such as E. coli and Fusobacterium nucleatum produce genotoxins (e.g., colibactin) and ROS that induce DNA strand breaks and impair host DNA repair in aging tissues.
  • Commensal SCFA-producing microbes enhance telomerase activity and mitigate oxidative stress, thereby preserving telomere length and cellular function.
  • Intervention studies in murine models demonstrate that antibiotic treatment and fecal microbiota transplantation reduce inflammatory cytokines, restore genomic stability, and slow telomere attrition.

Why it matters: Understanding microbial influence on DNA stability and telomere maintenance could revolutionize anti-aging strategies by targeting the gut microbiome.

Q&A

  • What is telomere attrition?
  • How do short-chain fatty acids (SCFAs) protect genomic stability?
  • What role do genotoxins like colibactin play in aging?
  • What is fecal microbiota transplantation (FMT)?
Copy link
Facebook X LinkedIn WhatsApp
Share post via...
Exploring the link between microbial balance and aging mechanisms

A team at Beijing Jiaotong University examines how organizational AI integration enhances employee knowledge sharing by creating learning opportunities. Surveying 364 employees, structural equation modeling reveals that paradoxical leadership and technophilia positively moderate the indirect effect of AI adoption on knowledge exchange, offering evidence-based guidelines for managers.

Key points

  • AI adoption directly increases learning opportunities (β=0.169, p<0.001) in SEM analysis of 364 employees.
  • Learning opportunities mediate the AI–knowledge sharing link with an indirect effect of 0.047 (95% CI[0.030,0.066]).
  • Paradoxical leadership and technophilia significantly strengthen both the AI–learning relationship (β=0.119, p<0.001; β=0.045, p<0.05) and the downstream knowledge-sharing pathway.

Why it matters: By identifying learning opportunities, leadership style, and technophilia as key drivers, this research offers strategies to maximize AI-driven collaboration.

Q&A

  • What is paradoxical leadership?
  • How do learning opportunities mediate AI adoption and knowledge sharing?
  • What is technophilia and why does it matter?
  • How was the research conducted?
Copy link
Facebook X LinkedIn WhatsApp
Share post via...

In an excerpt from The Optimist, journalist Keach Hagey details how Peter Thiel’s investments, guided by Eliezer Yudkowsky’s AI visions, seeded innovations like DeepMind and catalyzed OpenAI’s emergence through strategic mentorship and network support.

Key points

  • DeepMind’s Atari Breakout agent uses deep neural networks and reinforcement learning to achieve human-level performance without supervision.
  • Yudkowsky’s Singularity Institute pioneered friendly AI research, introducing alignment frameworks like Coherent Extrapolated Volition.
  • Peter Thiel’s Founders Fund investment in DeepMind and connections with Y Combinator catalyzed the creation of AGI ventures such as OpenAI.

Why it matters: This historical insight underscores the pivotal role of vision-driven funding networks in shaping the trajectory of artificial general intelligence research and entrepreneurial ecosystems.

Q&A

  • What is the Singularity Institute?
  • How does DeepMind’s Atari Breakout agent learn?
  • What distinguishes artificial general intelligence (AGI)?
  • What is Coherent Extrapolated Volition (CEV)?
Copy link
Facebook X LinkedIn WhatsApp
Share post via...
How Peter Thiel’s Relationship With Eliezer Yudkowsky Launched the AI Revolution

A report by The Research Insights forecasts the Artificial Intelligence in Diagnostics market expanding from USD 1.97 billion in 2025 to USD 5.44 billion by 2030 (CAGR 22.46%), underpinned by government funding, big data integration, and cross-industry partnerships that enhance imaging triage and clinical decision support.

Key points

  • Market projected to grow from USD 1.97 B in 2025 to USD 5.44 B by 2030 at a 22.46% CAGR.
  • Software leads with 45.81% revenue share; hardware imaging tools and services support adoption.
  • North America holds 54.74% market share; key players include Siemens Healthineers, GE Healthcare, Aidoc.

Why it matters: AI-driven diagnostics promise to revolutionize early disease detection, reduce clinical workloads, and deliver accuracy beyond traditional imaging techniques.

Q&A

  • What drives the AI diagnostics market growth?
  • How do AI models improve diagnostic accuracy?
  • What are the regulatory challenges for AI diagnostics?
  • How is data integration managed in AI diagnostic platforms?
Copy link
Facebook X LinkedIn WhatsApp
Share post via...

Paramendra Kumar Bhagat argues that AI constitutes a transformative wave that not only fuels robotics, biotech, and quantum computing but also catalyzes their convergence. By transcending outdated scarcity-based economic metrics, this acceleration challenges existing capitalist structures and invites a shift toward decentralized, intelligence-driven abundance. Bhagat leverages scriptural prophecies to frame this technological inflection as a historically unprecedented juncture with profound societal and spiritual implications.

Key points

  • AI acts as an accelerant across robotics, biotech, and quantum computing by providing generative algorithms for design and optimization.
  • Decentralized intelligent architectures challenge scarcity-driven economic metrics like GDP and labor productivity, signaling a shift toward abundance.
  • Ethical alignment and governance reform frameworks, inspired by scriptural prophecies, are proposed to manage intelligence-fueled post-scarcity dynamics.

Q&A

  • What is the 'AI wave'?
  • How does AI accelerate other technologies?
  • What does 'breaking capitalism' mean in this context?
  • Why reference scriptural prophecies?
Copy link
Facebook X LinkedIn WhatsApp
Share post via...
The Age of Abundance: AI, Acceleration, and the Prophecies of Tomorrow